Events

A monthly conversation about medicine, biology, computers, and entrepreneurship. About this event Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all. Featured speaker: Vivian S. Lee, MD, PhD, MBA, President of Health Platforms at Verily Life Sciences, and senior lecturer at Harvard Medical School

In this virtual fireside chat, Stanley Shaw will talk with Todd Park, co-founder of Devoted Health, Athenahealth, and Castlight Health and former U.S. chief technology officer, about drivers of successful innovation in health care and the leadership lessons that Todd has learned over 25 years of work as a change agent across the private and public sectors.

Hannah Neprash, PhD studies health economics, focusing on how health care providers respond to financial and non-financial incentives. Her research uses novel sources of data to examine how physician decision-making drives utilization, spending, access, and quality in health care. She is particularly interested in research questions that will inform evidence-based policy during a time of rapid transformation in health care […]

The Harvard Health Systems Innovation Lab is organizing a hackathon focusing on digital innovations to improve Type One Diabetes care in Africa. We are collaborating with the Global Collaborative for Changing Diabetes in Children (CDIC). CDIC is an initiative founded in 2009 which provides medicines and services to children with diabetes in a range of LMICs worldwide. The aim of […]

The 2022 Leadership and Faculty Development Program Conference and Minority Health Policy Annual Meeting will be held virtually, May 3rd through May 6th. Join us for rich discussions with clinicians and scholars about advancing health equity and addressing health disparities impacting the nation’s most vulnerable populations.

Abstract: The Institute for Clinical and Economic Review (ICER) fills a unique role in the U.S. health care landscape. As it passes its 15th year in operation, ICER’s impact has never been greater, yet significant obstacles still remain. What have been the lessons learned about conducting and communicating cost-effectiveness analyses for decision-makers in the U.S.? Steve Pearson, the Founder of […]

Crisis standards of care are guidelines that inform health care systems’ decisions around access to scarce medical resources. This includes access to medical beds, ventilators, medications, dialysis, extracorporeal membrane oxygenation, and other resources. The concept has received increased attention as the COVID-19 pandemic has challenged our health care systems. These guidelines pose concerns about the equitable provision of care. Chief […]

HBS Prof. Rem Koning will lead a discussion with alumnae Anula Jayasuriya (MBA 1993) and Halle Tecco (MBA 2011), who will share their experiences investing in women-led health care companies creating innovative products and services to address health needs most relevant to women. They will also weigh in on how we can better define "women's health” as a concept and […]

The federal 340B drug discount program provides certain providers with deep discounts on some outpatient drugs. Last year the 340B program saw substantial growth amidst uncertainty related to the use of contract pharmacies. The health care data and analytics firm, IQVIA, reported that in 2021, 340B program sales reached $93.6 billion and grew 15.9% year-on-year. However, last year more pharmaceutical […]

Join us for our next UMN MILI lab chat, where we talk to experts about key healthcare business topics every month. This May, we will talk to John O'Brien PharmD MPH, CEO of the National Pharmaceutical Council. This organization sponsors and participates in research on the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation. As […]